Symbols

FATE

Fate Therapeutics·NASDAQ

--(--)

3.81 / 10

Netural

Analyst sentiment is neutral: 33% Strong Buy, 33% Buy, 33% Neutral, but historical win rates are zero and past returns negative. Fund flow is strong (7.61/10) with small‑cap buying yet larger‑cap outflows, indicating mixed but overall positive capital interest.

Fund Flow Rating

Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

33%

Buy

33%

Hold

Sell

Strong Sell

Date2025-10-27

InstitutionWedbush

Times predicted1

Historical Win Rate0.0%

Is money flowing into or out of FATE?

FATE holds a Bearish analyst rating, with 33% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.81/10 (Netural).